Do corticosteroids compromise survival in cases of glioblastoma? In a retrospective analysis of clinical cohorts, Pitter et al. identify dexamethasone (DEX) use during radiotherapy as an independent indicator of shorter survival. Moreover, DEX pretreatment reduces survival in irradiated glioblastoma-bearing mice. Anti-VEGFA antibodies may counter oedema without compromising radiation efficacy.